Last reviewed · How we verify
NCT07293104: ChiPS
Children in Pancreatic Surgery: Indications, Procedures and Outcomes
trial testing Pancreatoduodenectomy in Pancreatic Surgery in 761 participants. Completed in 31 December 2023.
31 December 2023
Quick facts
| Lead sponsor | Medizinische Hochschule Brandenburg Theodor Fontane |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 761 |
| Start date | 1 January 2010 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 December 2023 |
Drugs / interventions tested
- Pancreatoduodenectomy
- Total pancreatectomy
- Distal pancreatectomy
- Anastomosis of the pancreatic duct
- Incision of the pancreas
- Internal drainage of the pancreas
- Local excision destruction pancreas
- Marsupialization of a pancreatic cyst
- Segmental pancreatic resection
Conditions studied
- Pancreatic Surgery — all drugs for Pancreatic Surgery →
- Children — all drugs for Children →
Sponsor
Medizinische Hochschule Brandenburg Theodor Fontane
Who can join
Under 18, any sex, with Pancreatic Surgery or Children. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pediatric patients differ in a variety of properties from adult populations, but comprehensive multicenter or population-based data is missing for pancreatic surgery. This study aimed to evaluate indications, complications, and mortality in pediatric pancreatic surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07293104
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Pancreatoduodenectomy
Trials testing the same drug.
- NCT04847297 — Preoperative Biliary Drainage in Malignant Biliary Obstruction · not yet recruiting
- NCT04381702 — Outcome After Laparoscopic Versus Open Pancreaticoduodenectomy · completed
Other recruiting trials for Pancreatic Surgery
Currently open trials in the same condition.
- NCT07248527 — PAN-ICIS Study: ICIS for Early Detection of Infectious Complications in Pancreatic Surgery · active not recruiting
- NCT05603702 — STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis · Phase 1 · recruiting
- NCT06381362 — Italian Registry of Minimally Invasive Pancreatic Surgery · recruiting
Other Medizinische Hochschule Brandenburg Theodor Fontane trials
Trials by the same sponsor.
- NCT06902337 — Gender Differences in Gastric Cancer Care and Its Adherence to Guidelines in Germany · active not recruiting
- NCT07017153 — Patient Decision Aids for Hypertension: A Pilot Study · NA · completed
- NCT06575582 — Digital Navigators for Acceptance and Competence Development with Mental Health Apps · NA · recruiting
- NCT06631560 — Hepatitis E Virus Infection in Oncological Patients · NA · completed
- NCT03052283 — Development and Validation of a Disease Specific PROM to Assess Abdominal Involvement in Patients With CF (CFAbd-Score) · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07293104 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medizinische Hochschule Brandenburg Theodor Fontane
- Last refreshed: 24 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07293104.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing